| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Emicizumab | LP430961-5 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | PPP | LP7494-0 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | Coag | LP6186-3 |
| parent | Emicizumab | Platelet poor plasma | Drug toxicology | LP431555-4 |
| parent | Emicizumab | Platelet poor plasma | Drug toxicology | LP431555-4 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/mL | |
| EXAMPLE_UCUM_UNITS | ug/mL | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay |
| LONG_COMMON_NAME | en-US | Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay |
| SHORTNAME | en-US | Emicizumab PPP-mCnc |
| ConsumerName | en-US | Emicizumab, Blood |
| LONG_COMMON_NAME | fr-FR | Emicizumab [Masse/Volume] Plasma pauvre en plaquettes ; Numérique ; Coagulation |
| LONG_COMMON_NAME | nl-NL | Emicizumab [massa/volume] in plaatjesarm plasma d.m.v. stollingsmethode |
| LinguisticVariantDisplayName | de-AT | Emicizumab |
LOINC Version: 2.77
FHIR